If you knew that virtually the entire medical community was talking about an issue causing risk and harm to patients across the country, wouldn’t you want to know what it is and take part in the conversation?
Recently federal and provincial health ministers agreed to create a working group to explore how to improve Canadians’ access to pharmaceutical drugs. In the wake of this, there is new optimism that pharmacare, publicly funded and universally available to Canadians, might one day come to pass.
I am privileged to help patients deal with a variety of common disorders such as ear infections, pharyngitis and sinus inflammation. People suffer a great deal from these problems, especially when they are in the acute phase.